Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments

Journal of Neuroscience

Volumn 21, Issue 16, 2001, Pages 6026-6035

  Ishihara, Takeshi ^a   Higuchi, Makoto ^a   Zhang, Bin ^a   Yoshiyama, Yasumasa ^a   Hong, Ming ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Animal models; Cytoskeleton; Neurodegeneration; Neurofi brillary pathology; Neurofilaments; Tau

Indexed keywords

NEUROFILAMENT PROTEIN; TAU PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL VIABILITY; DEGENERATIVE DISEASE; GENE OVEREXPRESSION; MOUSE; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; SPINAL CORD; TRANSGENIC MOUSE; WEIGHT REDUCTION;

EID: 0035882526     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-16-06026.2001     Document Type: Article

References (49)

1. The distribution of tau in the mammalian central nervous system
2. Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns
3. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
4. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis
5. Immunostaining of neurofibrillary tangles in Alzheimer's senile dementia with a neurofilament antiserum
6. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
7. Requirement of heavy neurofilament subunit in the development of axons with large calibers
8. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
9. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein
10. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
11. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
12. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites
13. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
14. Tau-based neurofibrillary lesions
15. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
16. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
17. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice
18. Neurofilament functions in health and disease
19. Epitopes that span the tau molecule are shared with paired helical filaments
20. Immunological and conformation characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease
21. Novel monoclonal antibodies provide evidence for the in situ existence of a nonphosphorylated form of the largest neurofilament subunit
22. A68: A major subunit of paired helical filaments and derivatized forms of normal Tau
23. Neurodegenerative tauopathies
24. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
25. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases
26. Immunohistochemical localization of neurofilament protein in neuronal degenerations
27. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
28. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components
29. Tau is a candidate gene for chromosome 17 frontotemporal dementia
30. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
31. Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation
32. Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus
33. Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles
34. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
35. Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonismdementia of Guam
36. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
37. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
38. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location
39. A simple silver-gold intensification procedure for double DAB labeling studies in electron microscopy
40. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: Implications for the pathogenesis of Parkinson disease and Lewy body dementia
41. Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits
42. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
43. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
44. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons
45. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease
46. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
47. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation
48. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments
49. Disruption of the NF-H gene increases axonal microtubule content and velocity of neurofilament transport: Relief of axonopathy resulting from the toxin beta,beta′-iminodipropionitrile